BONESUPPORT Q3 - Buckle up for high top and bottom-line growth
2023-10-27 09:45:00
Redeye returns with more flesh on the bones and presents its estimate changes on the back of the Q3 report. Thanks to its high operating leverage and so-far highly successful US CERAMENT G launch, we anticipate the EBIT margin to expand nicely in the coming quarters. While we leave our base case unchanged, we point to our increased bear case.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/